Enzyme by Design

The mission of Enzyme by Design is to make superior and safer biologics for cancer patients with high unmet needs. The company is a preclinical stage oncology therapeutic company focused on utilizing structural biology-guided protein engineering to create improved treatments that physicians desire and patients need—drugs that effectively eradicate tumor cells and do so safely, creating great promise of pan-cancer applicability using a precision medicine biomarker-driven approach. Its preclinical efficacy and toxicology data are highly compelling, and its team is knowledgeable and passionate about improving outcomes for patients living with cancer.